ArticleFrontiers in oncology2021

Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma.

Xiaorui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.